Stefan Sperl
Director de Operaciones en KIORA PHARMACEUTICALS, INC. .
Cargos activos de Stefan Sperl
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| KIORA PHARMACEUTICALS, INC. | Director de Operaciones | - | - |
Historial de carrera de Stefan Sperl
Antiguos cargos conocidos de Stefan Sperl.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Corporate Officer/Principal | - | - |
Panoptes Pharma GmbH
 Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Director de Operaciones | 01/07/2013 | - |
| Fundador | 01/07/2013 | - |
Formación de Stefan Sperl.
| Max Planck Institute of Biochemistry | Doctorate Degree |
Estadísticas
Internacional
| Austria | 3 |
| Estados Unidos | 2 |
| Alemania | 2 |
Operativa
| Chief Operating Officer | 2 |
| Founder | 1 |
| Corporate Officer/Principal | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KIORA PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Panoptes Pharma GmbH
Panoptes Pharma GmbH BiotechnologyHealth Technology Panoptes Pharma GmbH develops molecule drugs to treat eye diseases. The firm focuses on a new treatment for autoimmune uveitis, a disease which is one of the major causes of blindness. The company was founded by Franz Obermayr and Stefan Sperl in July 2013 and is headquartered in Wien, Austria. | Health Technology |
Nabriva Therapeutics GmbH
Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Health Technology |
- Bolsa de valores
- Insiders
- Stefan Sperl
- Experiencia
